期刊文献+

c-erbB-2过表达、nm23低表达与结直肠癌预后不良的关系 被引量:20

Overexpression of c-erbB-2 and hypoexpression of nm23 relating to poor prognosis of colorectal carcinoma
原文传递
导出
摘要 目的 探讨结直肠癌c erbB 2、CD4 4v6、nm2 3基因蛋白表达与临床病理特征的相关性及意义。方法 用免疫组织化学SP法检测了 92例结直肠癌组织c erbB 2、CD4 4v6、nm2 3蛋白表达 ,并对其中随访 10年以上的 2 8例作了生存分析。结果 c erbB 2和CD4 4v6的表达均与国际抗癌联盟(UICC)分期有关 (P <0 0 5 ) ,而且c erbB 2表达还与显著的瘤周淋巴样细胞浸润有关 (P <0 0 5 )。在随访 10年以上的 2 8例中 ,单因素分析显示 :患者生存率与组织分型、UICC分期、肿瘤生长方式、瘤周淋巴样细胞浸润以及c erbB 2、CD4 4v6、nm2 3表达均有关。但经多因素Cox比例风险分析 ,只有UICC分期、c erbB 2和nm2 3表达具有独立的预后意义。结论 除UICCⅢ、Ⅳ期之外 ,c erbB 2过表达和nm2 Objective To investigate the relationship between expression of c erbB 2, CD44v6 and nm23 gene proteins and the clinicopathological features of colorectal carcinomas Methods Immunohistochemical technique was adopted to detect the protein expression of c erbB 2, CD44v6 and nm23 genes in 92 cases of colorectal carcinomas Of the 92 cases, 28 cases were followed up for more than 10 years, in which the prognosis was analyzed Results Expression of c erbB 2 and CD44v6 was correlating with UICC staging ( P <0 05), and c erbB 2 was associated with prominent peritumoral lymphocytic infiltration ( P <0 05) In the 28 cases with followed up data, univariant analysis revealed that the survival rate was correlated with histological grading, UICC staging, tumor growth pattern, peritumoral lymphocytic infiltration, and expression of c erbB 2, CD44v6 and nm23 However, Cox stepwise proportional hazards analysis showed that only UICC staging, c erbB 2 and nm23 status retained significant independently in prospecting prognosis Conclusions Besides UICC Ⅲ and Ⅳ stage, overexpression of c erbB 2 and decreased expression of nm23 are considered acceptable as the parameters in predicting of poor prognosis in colorectal carcinoma
出处 《中华病理学杂志》 CAS CSCD 北大核心 2003年第2期115-119,共5页 Chinese Journal of Pathology
关键词 C-ERBB-2 表达 nm23低表达 结直肠癌 预后 Colorectal neoplasms Immunohistochemistry Prognosis
  • 相关文献

参考文献12

  • 1Nanashima A, Yamagnchi H, Sawai T, et al. Expression of adhesion molecules in hepatic metastases of colorectal carcinoma: relationship to primary tumours and prognosis after hepatic resection. J Castroenterol Hepatol, 1999, 14: 1004-1009.
  • 2Ishida T. Immunohistochemical expression of CD44 variant 6 in colorectal adenocarcinoma. Surg Today, 2000, 30: 28-32.
  • 3Tannapfel A, Kockerling F, Katalinic A, et al. Expression of nm23H1 predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum, 1995, 38 : 651-654.
  • 4Forte A, D "Urso A, Gallinaro LS, et al. NM23 expression as prognostic factor in colorectal carcinoma. G Chir, 2002, 23: 61-63.
  • 5Beahrs OH. Staging of cancer of the colon and rectum. Cancer,1992, 70: 1393-1396.
  • 6Hayes DF, Thor AD. c-erbB-2 in breast cancer: development of a clinically useful marker. Semin Oncol, 2002, 29: 231-245.
  • 7Yang JL, Ow KT, Russell PJ, et al. Higher expression of oncoproteins c-myc, c-erbB-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors. Ann Surg Oncol,1996, 3: 574-579.
  • 8Nakae S, Shimada E, Urakawa T. Study of c-erbB-2 protein and epidermal growth factor receptor expression and DNA ploidy pattern in colorectal carcinoma. J Surg Oncol, 1993, 54: 246-251.
  • 9Morrin M, Delaney PV. CD44v6 is not relevant in colorectal tumour progression. Int J Colorectal Dis, 2002, 17 : 30-36.
  • 10Chun SY, Bae OS, Kim JB. The significance of CD44 variants expression in colorectal cancer and its regional lymph nodes. J Korean Med Sci, 2000, 15: 696-700.

同被引文献159

引证文献20

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部